Search research articles
Contact Us
Filters
Showing results (621-630 of 831) with videos related to
Page
of 84
Sort By:
Contemporary Clinical Trials
|
November 20, 2025
Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD
Gelareh Sadigh, Fenghai Duan, Ilana F Gareen, et al.
Breast Cancer Research and Treatment
|
June 11, 2008
The impact of sharing results of a randomized breast cancer clinical trial with study participants
Ann H Partridge, A C Wolff, P K Marcom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2008
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
Harold J Burstein, Anthony D Elias, Hope S Rugo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile
Antonio C Wolff, Ross C Donehower, M Katherine Carducci, et al.
Clinical Breast Cancer
|
February 6, 2010
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer
Saranya Chumsri, Stacie Jeter, Lisa K Jacobs, et al.
BMC Genomics
|
February 6, 2016
A betabaculovirus encoding a gp64 homolog
Daniel M P Ardisson-Araújo, Bruna T Pereira, Fernando L Melo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Scientific Reports
|
June 11, 2016
The complete genome of a baculovirus isolated from an insect of medical interest: Lonomia obliqua (Lepidoptera: Saturniidae)
C W Aragão-Silva, M S Andrade, D M P Ardisson-Araújo, et al.
Breast (Edinburgh, Scotland)
|
March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials
Laura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2009
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women
Ani Balmanoukian, Zhe Zhang, Stacie Jeter, et al.
Page
of 84
Search research articles
Search
Showing results (621-630 of 831) with videos related to
Sort By:
Page
of 84
Contemporary Clinical Trials
|
November 20, 2025
Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD
Gelareh Sadigh, Fenghai Duan, Ilana F Gareen, et al.
Breast Cancer Research and Treatment
|
June 11, 2008
The impact of sharing results of a randomized breast cancer clinical trial with study participants
Ann H Partridge, A C Wolff, P K Marcom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2008
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
Harold J Burstein, Anthony D Elias, Hope S Rugo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile
Antonio C Wolff, Ross C Donehower, M Katherine Carducci, et al.
Clinical Breast Cancer
|
February 6, 2010
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer
Saranya Chumsri, Stacie Jeter, Lisa K Jacobs, et al.
BMC Genomics
|
February 6, 2016
A betabaculovirus encoding a gp64 homolog
Daniel M P Ardisson-Araújo, Bruna T Pereira, Fernando L Melo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Scientific Reports
|
June 11, 2016
The complete genome of a baculovirus isolated from an insect of medical interest: Lonomia obliqua (Lepidoptera: Saturniidae)
C W Aragão-Silva, M S Andrade, D M P Ardisson-Araújo, et al.
Breast (Edinburgh, Scotland)
|
March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials
Laura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2009
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women
Ani Balmanoukian, Zhe Zhang, Stacie Jeter, et al.
Page
of 84